| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |